Featured Inquiries and Replies
Ask an Expert
Lung Cancer
Lung Cancer Specialist
Hematologist, Oncologist
Would you add chemotherapy to IO in the setting of low volume disease metastatic Adenocarcinoma of the lung with PDL-1 80%?
Read Response
Multiple Myeloma
Multiple Myeloma Specialist
Hematologist, Oncologist
For patients who are s/p melphalan auto SCT and in need of post-transplant vaccinations, if their serum immunoglobulins remain low at the 6 month point when vaccinations would be due, would you delay their vaccinations?
Read Response
MPN | Age 46 | New Dx
MPN Specialist
Hematologist, Oncologist
I’m working up a patient for erythrocytosis. His BMBx was mildly hypocellular at 20-40% for a 46yo (heavy EtOH use) and cytogenetics and myeloid NGS panel were normal and without mutations respectively. Do you think his EtOH could be masking the expected panmyelosis of PV?
Read Response
Lung Cancer | Age 70 | New Dx
Lung Cancer Specialist
Hematologist, Oncologist
70 y/o with met. NSCLC developed colitis on maintenance pembro. Excellent response to steroids but colitis recurs after taper. Got restarted on steroids and now starting on infliximab. Do you continue the steroids or stop/ taper them?
Read Response
Multiple Myeloma | Age 58
Multiple Myeloma Specialist
Hematologist, Oncologist
58M with IgG lambda MM, R-ISS 1, standard risk cytogenetics. Recently, developed localized prostate cancer. Would you stop revlimid maintenance in setting of another cancer?
Read Response
Lymphoma | Oncology Pharmacist
Oncology Pharmacist
65 year-old patient with stage III Hodgkin's is having a tough time with Bren-AVD. I'm thinking patient will need dose reductions or delays. Any ideas on how to manage side effects?
Read Response
Ask an Expert
Disclaimer: These are examples of platform discussions and should be viewed for educational purposes only.